(Q36908784)

17 August 2017

1 reference

title

Initiation of primary anti-vaccinia virus immunity in vivo (English)

1 reference

17 August 2017

vaccinia virus

1 reference

Matthew A Fischer

1

1 reference

17 August 2017

Christopher C Norbury

series ordinal

2

1 reference

17 August 2017

publication date

1 January 2007

1 reference

17 August 2017

1 reference

17 August 2017

volume

37

1 reference

17 August 2017

issue

2

1 reference

17 August 2017

page(s)

113-133

1 reference

A study of the vaccinia virus interferon-gamma receptor and its contribution to virus virulence

17 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF02685894

A model for vaccinia virus pathogenesis and immunity based on intradermal injection of mouse ear pinnae

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02685894

Dermal infection with vaccinia virus reveals roles for virus proteins not seen using other inoculation routes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02685894

Neutrophil uptake of vaccinia virus in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02685894

Interactions between human neutrophils and vaccinia virus: induction of oxidative metabolism and virus inactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02685894

Innate immunity to viruses: control of vaccinia virus infection by gamma delta T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02685894

Cellular and humoral immunity against vaccinia virus infection of mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02685894

Identification of murine poxvirus-specific CD8+ CTL epitopes with distinct functional profiles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02685894

HLA-A*0201, HLA-A*1101, and HLA-B*0702 transgenic mice recognize numerous poxvirus determinants from a wide variety of viral gene products.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02685894

Cutting edge: conventional CD8 alpha+ dendritic cells are generally involved in priming CTL immunity to viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02685894

Inhibitory effects of cytomegalovirus proteins US2 and US11 point to contributions from direct priming and cross-priming in induction of vaccinia virus-specific CD8(+) T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02685894

Direct priming and cross-priming contribute differentially to the induction of CD8+ CTL following exposure to vaccinia virus via different routes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02685894

Presentation of cytosolic antigen by HLA-DR requires a function encoded in the class II region of the MHC.

21 January 2018

1 reference

12 December 2020

The mononuclear phagocyte system of the mouse defined by immunohistochemical localization of antigen F4/80. Relationship between macrophages, Langerhans cells, reticular cells, and dendritic cells in lymphoid and hematopoietic organs.

1 reference

12 December 2020

Enhancing the potency of peptide-pulsed antigen presenting cells by vector-driven hyperexpression of a triad of costimulatory molecules

1 reference

12 December 2020

Irreversible association of peptides with class II MHC molecules in living cells.

1 reference

12 December 2020

Gamma interferon-induced, nitric oxide-mediated inhibition of vaccinia virus replication

1 reference

12 December 2020

Recovery of immunodeficient mice from a vaccinia virus/IL-2 recombinant infection

1 reference

12 December 2020

Recognition and destruction of virus-infected cells by human gamma delta CTL.

1 reference

12 December 2020

THE FATE OF VACCINIA VIRUS ON CULTIVATION IN VITRO WITH KUPFFER CELLS (RETICULO-ENDOTHELIAL CELLS).

1 reference

12 December 2020

Species specificity of ectromelia virus and vaccinia virus interferon-gamma binding proteins

1 reference

12 December 2020

Invariant chain protects class II histocompatibility antigens from binding intact polypeptides in the endoplasmic reticulum

1 reference

12 December 2020

Biological activity of an intravenous preparation of human vaccinia immune globulin in mouse models of vaccinia virus infection

1 reference

12 December 2020

Quantitation of CD8+ T cell responses to newly identified HLA-A*0201-restricted T cell epitopes conserved among vaccinia and variola (smallpox) viruses

1 reference

12 December 2020

Antigen expression by dendritic cells correlates with the therapeutic effectiveness of a model recombinant poxvirus tumor vaccine

1 reference

12 December 2020

TRICOM vector based cancer vaccines.

1 reference

12 December 2020

Protection against lethal vaccinia virus challenge in HLA-A2 transgenic mice by immunization with a single CD8+ T-cell peptide epitope of vaccinia and variola viruses

1 reference

12 December 2020

Myopericarditis following smallpox vaccination among vaccinia-naive US military personnel

1 reference

12 December 2020

Presentation of endogenous viral proteins in association with major histocompatibility complex class II: on the role of intracellular compartmentalization, invariant chain and the TAP transporter system

1 reference

12 December 2020

Intratumoral vaccination and diversified subcutaneous/ intratumoral vaccination with recombinant poxviruses encoding a tumor antigen and multiple costimulatory molecules

1 reference

12 December 2020

Induction of antitumor immunity by recombinant vaccinia viruses expressing B7-1 or B7-2 costimulatory molecules

1 reference

12 December 2020

Beta 2-microglobulin-, CD8+ T-cell-deficient mice survive inoculation with high doses of vaccinia virus and exhibit altered IgG responses

1 reference

12 December 2020

Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications

1 reference

12 December 2020

Artificial antigen-presenting cells engineered by recombinant vaccinia viruses expressing antigen, MHC class II, and costimulatory molecules elicit proliferation of CD4+ lymphocytes in vitro

1 reference

12 December 2020

Identification of vaccinia virus epitope-specific HLA-A*0201-restricted T cells and comparative analysis of smallpox vaccines.

1 reference

12 December 2020

Inhibition of viral replication by nitric oxide and its reversal by ferrous sulfate and tricarboxylic acid cycle metabolites

1 reference

12 December 2020

4-1BB ligand enhances tumor-specific immunity of poxvirus vaccines

1 reference

12 December 2020

The role of interferon in vaccinia virus infection of mouse embryo tissue culture

1 reference

12 December 2020

Specific Macrophage Immunity to Vaccinia Virus: Macrophage-Virus Interaction

1 reference

12 December 2020

Shared modes of protection against poxvirus infection by attenuated and conventional smallpox vaccine viruses

1 reference

12 December 2020

Expression of mouse interleukin-4 by a recombinant ectromelia virus suppresses cytolytic lymphocyte responses and overcomes genetic resistance to mousepox.

1 reference

12 December 2020

Lymphocyte and macrophage responses after vaccinia virus infections.

1 reference

12 December 2020

Immune modulation by proteins secreted from cells infected by vaccinia virus.

1 reference

12 December 2020

Identification of vaccinia CD8+ T-cell epitopes conserved among vaccinia and variola viruses restricted by common MHC class I molecules, HLA-A2 or HLA-B7.

1 reference

12 December 2020

In vitro assessment of cellular immunity to vaccinia virus: contribution of lymphocytes and macrophages

1 reference

12 December 2020

Processing pathways for presentation of cytosolic antigen to MHC class II-restricted T cells

1 reference

12 December 2020

Characteristics of NK cell migration early after vaccinia infection

1 reference

12 December 2020

Inhibition of Viral Replication by Interferon-γ-Induced Nitric Oxide Synthase

1 reference

12 December 2020

Immune defence in mice lacking type I and/or type II interferon receptors

1 reference

12 December 2020

Deletion of gene A41L enhances vaccinia virus immunogenicity and vaccine efficacy.

1 reference

12 December 2020

Local production of tumor necrosis factor encoded by recombinant vaccinia virus is effective in controlling viral replication in vivo

1 reference

12 December 2020

The detection of monkeypox in humans in the Western Hemisphere.

1 reference

12 December 2020

The roles of perforin- and Fas-dependent cytotoxicity in protection against cytopathic and noncytopathic viruses

1 reference

12 December 2020

The immunobiology of murine interleukin-1 alpha encoded by recombinant vaccinia virus

1 reference

12 December 2020

Window of vulnerability of vaccinia virus-infected cells to natural killer (NK) cell-mediated cytolysis correlates with enhanced NK cell triggering and is concomitant with a decrease in H-2 class I antigen expression

1 reference

12 December 2020

Immune recognition of a human renal cancer antigen through post-translational protein splicing.

1 reference

12 December 2020

Inactivation of the viral interleukin 1beta receptor improves CD8+ T-cell memory responses elicited upon immunization with modified vaccinia virus Ankara

1 reference

12 December 2020

Immunity and immunological memory following smallpox vaccination

1 reference

12 December 2020

IL-4 diminishes perforin-mediated and increases Fas ligand-mediated cytotoxicity In vivo

1 reference

12 December 2020

Anti-tumor immunity elicited by a recombinant vaccinia virus expressing CD70 (CD27L).

1 reference

12 December 2020

A kinetic analysis of immune mediators in the lungs of mice infected with vaccinia virus and comparison with intradermal infection

1 reference

12 December 2020

Immunodominance in major histocompatibility complex class I-restricted T lymphocyte responses

1 reference

12 December 2020

Alpha beta and gamma delta T-cell networks and their roles in natural resistance to viral infections

1 reference

12 December 2020

Prevention of vaccinia virus infection in immunodeficient mice by vector-directed IL-2 expression

1 reference

12 December 2020

Delayed hypersensitivity in vaccinia-infected mice. II. Resistance of peritoneal macrophages against vaccinia infection.

1 reference

12 December 2020

Recombinant vaccinia virus-induced T-cell immunity: quantitation of the response to the virus vector and the foreign epitope

1 reference

12 December 2020

Use of vaccinia virus expression vectors to investigate antigen processing and presentation

1 reference

12 December 2020

CD11c(+)B220(+)Gr-1(+) cells in mouse lymph nodes and spleen display characteristics of plasmacytoid dendritic cells

1 reference

12 December 2020

Biological effects of recombinant vaccinia virus-expressed interleukin 4

1 reference

12 December 2020

An investigation of the therapeutic value of vaccinia-immune IgG in a mouse pneumonia model

1 reference

12 December 2020

Viral infection switches non-plasmacytoid dendritic cells into high interferon producers.

1 reference

12 December 2020

Abortive replication of vaccinia virus in activated rabbit macrophages

1 reference

12 December 2020

Costimulation enhances the active immunotherapy effect of recombinant anticancer vaccines.

1 reference

12 December 2020

Creation of killer poxvirus could have been predicted

1 reference

12 December 2020

Perforin is essential for control of ectromelia virus but not related poxviruses in mice.

1 reference

12 December 2020

Cancer gene therapy using tumor cells infected with recombinant vaccinia virus expressing GM-CSF.

1 reference

12 December 2020

Interferon treatment inhibits early events in vaccinia virus gene expression in infected mice

1 reference

12 December 2020

Different roles for CD4+ and CD8+ T lymphocytes and macrophage subsets in the control of a generalized virus infection

1 reference

12 December 2020

Langerhans cells in vaccinia virus infection in mouse skin

1 reference

12 December 2020

The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes

1 reference

12 December 2020

A phase I trial of pox PSA vaccines (PROSTVAC-VF) with B7-1, ICAM-1, and LFA-3 co-stimulatory molecules (TRICOM) in patients with prostate cancer

1 reference

12 December 2020

Skin-derived dendritic cells induce potent CD8(+) T cell immunity in recombinant lentivector-mediated genetic immunization

1 reference

12 December 2020

Poxvirus entry and membrane fusion

1 reference

12 December 2020

Accumulation and chemotaxis of natural killer/large granular lymphocytes at sites of virus replication.

1 reference

12 December 2020

Poxvirus CD8+ T-cell determinants and cross-reactivity in BALB/c mice

1 reference

12 December 2020

Effect of rabbit anti-asialo GM1 treatment in vivo or with anti-asialo GM1 plus complement in vitro on cytotoxic T cell activities.

1 reference

12 December 2020

In vivo survival and homeostatic proliferation of natural killer cells.

1 reference

12 December 2020

Human monkeypox -- Kasai Oriental, Democratic Republic of Congo, February 1996-October 1997.

1 reference

12 December 2020

Ectromelia virus: the causative agent of mousepox

1 reference

12 December 2020

Visualizing priming of virus-specific CD8+ T cells by infected dendritic cells in vivo

1 reference

12 December 2020

Immunodominance of poxviral-specific CTL in a human trial of recombinant-modified vaccinia Ankara

1 reference

12 December 2020

Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice

1 reference

12 December 2020

Intradermal immune response after infection with Vaccinia virus

1 reference

12 December 2020

Phase I study of sequential vaccinations with fowlpox-CEA(6D)-TRICOM alone and sequentially with vaccinia-CEA(6D)-TRICOM, with and without granulocyte-macrophage colony-stimulating factor, in patients with carcinoembryonic antigen-expressing carcino

1 reference

12 December 2020

Vaccinia Virus B18R Gene Encodes a Type I Interferon-binding Protein That Blocks Interferon α Transmembrane Signaling

1 reference

12 December 2020

Construction and expression in tumor cells of a recombinant vaccinia virus encoding human interleukin-1 beta

1 reference

12 December 2020

Vaccinia virus inhibits the maturation of human dendritic cells: a novel mechanism of immune evasion.

1 reference

12 December 2020

Recognition of vaccinia virus-infected cells by human natural killer cells depends on natural cytotoxicity receptors

1 reference

12 December 2020

Vaccinia, cowpox, and camelpox viruses encode soluble gamma interferon receptors with novel broad species specificity

1 reference

12 December 2020

Analysis of an interaction between the soluble vaccinia virus-coded type I interferon (IFN)-receptor and human IFN-alpha1 and IFN-alpha2.

1 reference

12 December 2020

Vaccinia virus encodes a soluble type I interferon receptor of novel structure and broad species specificity

1 reference

12 December 2020

Efficiency of cross presentation of vaccinia virus-derived antigens by human dendritic cells

1 reference

12 December 2020

Quantitating protein synthesis, degradation, and endogenous antigen processing

1 reference

12 December 2020

The role of interleukin-6 in mucosal IgA antibody responses in vivo

1 reference

12 December 2020

HLA class I-restricted responses to vaccinia recognize a broad array of proteins mainly involved in virulence and viral gene regulation

1 reference

12 December 2020

Identification of poxvirus CD8+ T cell determinants to enable rational design and characterization of smallpox vaccines

1 reference

12 December 2020

Interleukin-4 mediates down regulation of antiviral cytokine expression and cytotoxic T-lymphocyte responses and exacerbates vaccinia virus infection in vivo

1 reference

12 December 2020

Immune response in mice that lack the interferon-gamma receptor

1 reference

12 December 2020

Peptide loading onto recycling HLA-DR molecules occurs in early endosomes

1 reference

12 December 2020

Smallpox: emergence, global spread, and eradication.

1 reference

12 December 2020

Interferon gamma is involved in the recovery of athymic nude mice from recombinant vaccinia virus/interleukin 2 infection

1 reference

12 December 2020

Novel vaccinia vector derived from the host range restricted and highly attenuated MVA strain of vaccinia virus

1 reference

12 December 2020

Highly attenuated smallpox vaccine protects mice with and without immune deficiencies against pathogenic vaccinia virus challenge

1 reference

12 December 2020

Targeting the local tumor microenvironment with vaccinia virus expressing B7.1 for the treatment of melanoma

1 reference

12 December 2020

Immunodeficient mice recover from infection with vaccinia virus expressing interferon-gamma.

1 reference

12 December 2020

Immunodominance analysis of CTL responses to influenza PR8 virus reveals two new dominant and subdominant Kb-restricted epitopes

1 reference

12 December 2020

Cytokine production and antitumor effect of a nonreplicating, noncytopathic recombinant vaccinia virus expressing interleukin-12.

1 reference

12 December 2020

Dendritic cells and the control of immunity

1 reference

12 December 2020

The toxic effect of vaccinia virus on leucocytes in vitro

1 reference

12 December 2020

Antigen gene transfer to human plasmacytoid dendritic cells using recombinant adenovirus and vaccinia virus vectors.

1 reference

12 December 2020

Interactions between vaccinia virus and sensitized macrophagesin vitro

1 reference

12 December 2020

A triad of costimulatory molecules synergize to amplify T-cell activation

1 reference

12 December 2020

Electron Microscope Study of the Interaction of Vaccinia Virus with Macrophages from Immunized and Nonimmunized Rabbits

1 reference

12 December 2020

Effects of virally expressed interleukin-10 on vaccinia virus infection in mice.

1 reference

12 December 2020

Interferon-gamma severely inhibits DNA synthesis of vaccinia virus in a macrophage cell line.

1 reference

12 December 2020

Langerhans cells arise from monocytes in vivo

1 reference

12 December 2020

Mature dendritic cells infected with canarypox virus elicit strong anti-human immunodeficiency virus CD8+ and CD4+ T-cell responses from chronically infected individuals

1 reference

12 December 2020

Expression of foreign genes in cultured human primary macrophages using recombinant vaccinia virus vectors

1 reference

12 December 2020

Admixture of a recombinant vaccinia virus containing the gene for the costimulatory molecule B7 and a recombinant vaccinia virus containing a tumor-associated antigen gene results in enhanced specific T-cell responses and antitumor immunity

1 reference

12 December 2020

Antiviral protection by virus-immune cytotoxic T cells: infected target cells are lysed before infectious virus progeny is assembled

1 reference

12 December 2020

Interleukin 17 modulates the immune response to vaccinia virus infection

1 reference

12 December 2020

Gene therapy death prompts review of adenovirus vector

1 reference

12 December 2020

Murine interferon lambdas (type III interferons) exhibit potent antiviral activity in vivo in a poxvirus infection model

1 reference

12 December 2020

Smallpox: a history of its rise and fall

1 reference

12 December 2020

Temporal regulation of influenza hemagglutinin expression in vaccinia virus recombinants and effects on the immune response

1 reference

12 December 2020

Interleukin-5 expressed by a recombinant virus vector enhances specific mucosal IgA responses in vivo.

1 reference

12 December 2020

Complications of smallpox vaccination, 1968.

1 reference

12 December 2020

Immunogenicity of a highly attenuated MVA smallpox vaccine and protection against monkeypox

1 reference

12 December 2020

Combinations of polyclonal or monoclonal antibodies to proteins of the outer membranes of the two infectious forms of vaccinia virus protect mice against a lethal respiratory challenge

1 reference

12 December 2020

Vaccinia virus H3L envelope protein is a major target of neutralizing antibodies in humans and elicits protection against lethal challenge in mice.

1 reference

12 December 2020

Induction of antigen-presenting capacity in tumor cells upon infection with non-replicating recombinant vaccinia virus encoding murine MHC class II and costimulatory molecules

1 reference

12 December 2020

Cellular ligands of activating NK receptors.

1 reference

12 December 2020

Smallpox vaccine-induced antibodies are necessary and sufficient for protection against monkeypox virus

1 reference

12 December 2020

Vaccinia virus proteins on the plasma membrane of infected cells. III. Infection of peritoneal macrophages

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02685894

1 reference

17 August 2017

1 reference